UnknownPhase 2NCT02969083
Feasibility of Neo-adjuvant Versus Adjuvant Chemotherapy in Upper Tract Urothelial Carcinoma
Studying Upper tract urothelial carcinoma
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- The European Uro-Oncology Group
- Principal Investigator
- Susanne Osanto, MD, PhD, M.D. Ph.DLeiden University Medical Centre
- Intervention
- RNU(procedure)
- Enrollment
- 200 target
- Eligibility
- 18 years · All sexes
- Timeline
- 2018 – 2025
Study locations (29)
- Radboud University Medical Centre, Nijmegen, Gelderland, Netherlands
- Leiden University Medical Centre, Leiden, South Holland, Netherlands
- Alrijne Ziekenhuis, Leiderdorp, South Holland, Netherlands
- Canisius Wilhelmina Ziekenhuis, Nijmegen, Netherlands
- Haukeland University Hospital, Bergen, Norway
- Complejo Hospitalario Universitario A Coruña, A Coruña, Spain
- Hospital Universitario German Trias i Pujol, Badalona, Spain
- Fundacion Puigvert, Barcelona, Spain
- Hospital Clinico de Barcelona, Barcelona, Spain
- Hospital San Pau, Barcelona, Spain
- Hospital Universitario Vall d'Hebron, Barcelona, Spain
- Hospital Universitario de Basurto, Bilbao, Spain
- Hospital Universitari de Girona Doctor Josep Trueta, Girona, Spain
- Hospital Universitario Clínico San Cecilio, Granada, Spain
- Hospital de Jerez, Jerez de la Frontera, Spain
- +14 more locations on ClinicalTrials.gov
Collaborators
Centre for Human Drug Research, Netherlands
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT02969083 on ClinicalTrials.govOther trials for Upper tract urothelial carcinoma
Additional recruiting or active studies for the same condition.
- RECRUITINGNCT07452432Korean Prospective Upper Tract Urothelial Carcinoma CohortSamsung Medical Center
- RECRUITINGNANCT07321210Radical Nephroureterectomy With vs Without Template Lymph Node Dissection in High-Risk Upper Tract Urothelial Carcinoma (T-LND UTUC): A Randomized Clinical TrialTianjin Medical University Second Hospital
- RECRUITINGPHASE2NCT07265947Phase 2A/B Efficacy and Safety of Dabogratinib in Participants With Low Grade Upper Tract Urothelial CarcinomaTyra Biosciences, Inc
- RECRUITINGPHASE2NCT07225374Cisplatin-Based Chemotherapy Followed by Maintenance Avelumab in UTUCSamsung Medical Center
- ACTIVE NOT RECRUITINGPHASE2NCT07492225Neoadjuvant Chemotherapy Before Surgery vs Surgery Alone for UTUC: A Randomized TrialChanghai Hospital
- RECRUITINGPHASE2NCT06356155Study of Neoadjuvant Enfortumab Vedotin and Pembrolizumab in Cisplatin-eligible Upper Tract Urothelial CancerUniversity of Michigan Rogel Cancer Center
- RECRUITINGPHASE2NCT07126119Neoadjuvant Tislelizumab in Combination With Nab-Paclitaxel for UTUCTianjin Medical University Second Hospital
- RECRUITINGPHASE1NCT06848868Ambulatory Flexible URS for UTUC SurveillanceChinese University of Hong Kong